Emmaus gains authorisation for sickle cell treatment in Oman

Emmaus Life Sciences has received marketing authorisation for Endari (L-glutamine oral powder) in Oman for sickle cell disease.

Related Keywords

Netherlands ,Israel ,Kuwait ,Saudi Arabia ,Qatar ,Bahrain ,Woman ,France ,Omani ,Victor Josan Shutterstock ,George Sekulich ,Oman Ministry Of Health ,Emmaus Life Sciences ,Victor Josan ,Life Sciences ,Oman Ministry ,